journavx drug - Search News

FDA Approves 1st-in-Class Non-Opioid Pain Drug Journavx

FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by Vertex Pharmaceuticals,

StudyFinds on MSN · 1d

Journavx: What to know about new FDA-approved non-opioid pain medication

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication after 25 years.

Axios on MSN · 12h

FDA approves Vertex non-opioid pain drug

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why it matters: Millions of Americans with acute and chronic pain are prescribed opioids,

The Boston Globe2d

At $31 a day, is Vertex’s new non-addictive painkiller worth the price?

That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...

3don MSN

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves 1st-in-Class Non-Opioid Pain Drug Journavx

Trending now